Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02637687
Title A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (SCOUT)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bayer

congenital fibrosarcoma

Advanced Solid Tumor

breast secretory carcinoma

benign neoplasm

congenital mesoblastic nephroma

central nervous system cancer



Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST